Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1930)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
510
Price
$578.26
Total Value
$294.91K
Shares Held After
44,033
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
490
Price
$577.27
Total Value
$282.86K
Shares Held After
44,543
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
751
Price
$575.93
Total Value
$432.53K
Shares Held After
45,033
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,245
Price
$575.15
Total Value
$716.06K
Shares Held After
45,784
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
888
Price
$574.01
Total Value
$509.72K
Shares Held After
47,029
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$573.01
Total Value
$501.96K
Shares Held After
47,917
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$571.79
Total Value
$411.69K
Shares Held After
48,793
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
500
Price
$569.70
Total Value
$284.85K
Shares Held After
49,513
% of Holdings
1.0%
RESMED INC (RMD)
Farrell Michael J. — Director
Shares
4,991
Price
$207.82
Total Value
$1.04M
Shares Held After
466,223
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
160
Price
$597.54
Total Value
$95.61K
Shares Held After
18,876
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$589.72
Total Value
$70.77K
Shares Held After
19,036
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$589.02
Total Value
$188.49K
Shares Held After
19,156
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
700
Price
$587.74
Total Value
$411.42K
Shares Held After
19,476
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
340
Price
$586.73
Total Value
$199.49K
Shares Held After
20,176
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
640
Price
$585.83
Total Value
$374.93K
Shares Held After
20,516
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$584.21
Total Value
$233.68K
Shares Held After
21,156
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$583.41
Total Value
$116.68K
Shares Held After
21,556
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$581.50
Total Value
$163.40K
Shares Held After
21,756
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
399
Price
$580.37
Total Value
$231.57K
Shares Held After
22,037
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$578.65
Total Value
$300.90K
Shares Held After
22,436
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
640
Price
$577.42
Total Value
$369.55K
Shares Held After
22,956
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,002
Price
$575.98
Total Value
$577.13K
Shares Held After
23,596
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,045
Price
$575.14
Total Value
$601.02K
Shares Held After
24,598
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,306
Price
$573.94
Total Value
$749.57K
Shares Held After
25,643
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
807
Price
$572.93
Total Value
$462.35K
Shares Held After
26,949
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$571.77
Total Value
$320.19K
Shares Held After
27,756
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$569.71
Total Value
$319.04K
Shares Held After
28,316
% of Holdings
1.9%
EXELIXIS, INC. (EXEL)
POSTE GEORGE — Director
Shares
60,000
Price
$45.71
Total Value
$2.74M
Shares Held After
118,832
% of Holdings
33.6%
EXELIXIS, INC. (EXEL)
Beckerle Mary C — Director
Shares
7,712
Price
$48.45
Total Value
$373.65K
Shares Held After
17,524
% of Holdings
30.6%
EXELIXIS, INC. (EXEL)
Freire Maria C — Director
Shares
20,634
Price
$46.00
Total Value
$949.16K
Shares Held After
100,819
% of Holdings
17.0%
Doximity, Inc. (DOCS)
Wampler Kira Scherer — Director
Shares
9,000
Price
$26.06
Total Value
$234.54K
Shares Held After
19,839
% of Holdings
31.2%
Axogen, Inc. (AXGN)
JOHNSON JOHN — Director
Shares
11,050
Price
$43.26
Total Value
$477.97K
Shares Held After
0
% of Holdings
100.0%
Axogen, Inc. (AXGN)
Kemp Jens — Chief Marketing Officer
Shares
4,000
Price
$43.44
Total Value
$173.76K
Shares Held After
72,451
% of Holdings
5.2%
Axogen, Inc. (AXGN)
Weiler Kathy Johnson — Director
Shares
16,344
Price
$44.09
Total Value
$720.62K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Perez Daniel Antonio — Director
Shares
45,456
Price
$55.05
Total Value
$2.50M
Shares Held After
35,470
% of Holdings
56.2%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
1,422
Price
$40.50
Total Value
$57.59K
Shares Held After
1,118
% of Holdings
56.0%
Vericel Corp (VCEL)
Mara Joseph Anthony Jr — Chief Financial Officer
Shares
5,000
Price
$40.50
Total Value
$202.50K
Shares Held After
21,009
% of Holdings
19.2%
Axogen, Inc. (AXGN)
Hartley Lindsey Marie — CFO
Shares
573
Price
$43.67
Total Value
$25.02K
Shares Held After
65,146
% of Holdings
0.9%
Axogen, Inc. (AXGN)
Hartley Lindsey Marie — CFO
Shares
478
Price
$43.67
Total Value
$20.87K
Shares Held After
62,756
% of Holdings
0.8%
Axogen, Inc. (AXGN)
Quackenbush Doris — Sales VP
Shares
3,878
Price
$43.51
Total Value
$168.72K
Shares Held After
92,416
% of Holdings
4.0%
InspireMD, Inc. (NSPR)
Stuka Paul — Director
Shares
6,378
Price
$1.15
Total Value
$7.33K
Shares Held After
531,599
% of Holdings
1.2%
InspireMD, Inc. (NSPR)
ROUBIN GARY S — Director
Shares
90,000
Price
$1.18
Total Value
$106.20K
Shares Held After
834,478
% of Holdings
10.8%
InspireMD, Inc. (NSPR)
Ward Scott R. — Director
Shares
73,255
Price
$1.15
Total Value
$84.24K
Shares Held After
237,096
% of Holdings
30.9%
908 Devices Inc. (MASS)
AWM Investment Company, Inc. — 10% Owner
Shares
12,819
Price
$8.20
Total Value
$105.17K
Shares Held After
5,124,740
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
9
Price
$155.25
Total Value
$1.40K
Shares Held After
0
% of Holdings
100.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
3
Price
$154.61
Total Value
$463.83
Shares Held After
9
% of Holdings
25.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
428
Price
$153.56
Total Value
$65.73K
Shares Held After
12
% of Holdings
97.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
226
Price
$152.45
Total Value
$34.45K
Shares Held After
440
% of Holdings
33.9%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.37
Total Value
$134.80K
Shares Held After
926,556
% of Holdings
4.1%
Orthofix Medical Inc. (OFIX)
HENNEMAN JOHN B III — Director
Shares
5,000
Price
$12.26
Total Value
$61.30K
Shares Held After
90,809
% of Holdings
5.5%
Showing 1401–1450 of 1930 transactions (page 29 of 39)